·
Our current research focuses on developing next-generation biologics aimed at enhancing the efficacy of cancer treatments. By engineering antibodies and other biologics, we strive to create targeted therapies that minimize side effects while maximizing tumor destruction. This research represents a major step forward in the fight against cancer and emphasizes our commitment to precision medicine.